RxSight (RXST) Income from Continuing Operations (2020 - 2026)

RxSight (RXST) posted Income from Continuing Operations of 15884000.0 for Q1 2026, down 73.56% on a QoQ basis from 9152000.0 in Q4 2025, and down 93.94% year-over-year from 262278145.16 in Q1 2025.

RxSight (RXST) Income from Continuing Operations (2020 - 2026) Analysis & Trends

RxSight's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 15884000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations fell 93.94% year-over-year to 15884000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 46638000.0 (down 76.31% YoY) and the FY2025 annual result came in at 38944000.0, down 42.32% from the prior year.
  • Income from Continuing Operations was 15884000.0 for Q1 2026 at RxSight, down from 9152000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 53507000.0 in Q4 2022 and bottomed at 17596000.0 in Q1 2022.
  • A 5-year average of 4095588.24 and a median of 9816000.0 in 2025 frame the typical range for Income from Continuing Operations.
  • Peak annual rise in Income from Continuing Operations reached 440.07% in 2022, while the deepest fall reached 158.57% in 2022.
  • RxSight's Income from Continuing Operations stood at 53507000.0 in 2022, then slipped by 7.23% to 49636000.0 in 2023, then plunged by 111.78% to 5846000.0 in 2024, then tumbled by 56.55% to 9152000.0 in 2025, then tumbled by 73.56% to 15884000.0 in 2026.
  • Business Quant data shows RXST's Income from Continuing Operations at 15884000.0 in Q1 2026, 9152000.0 in Q4 2025, and 9816000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 RxSight 221.81 Mn -196.39 Mn 23.50 Mn -15.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.88 Mn
Dec 31, 2025 -9.15 Mn
Sep 30, 2025 -9.82 Mn
Jun 30, 2025 -11.79 Mn
Mar 31, 2025 -8.19 Mn
Dec 31, 2024 -5.85 Mn
Sep 30, 2024 -6.34 Mn
Jun 30, 2024 -6.08 Mn
Mar 31, 2024 -9.10 Mn
Dec 31, 2023 49.64 Mn
Sep 30, 2023 -12.42 Mn
Jun 30, 2023 -13.80 Mn
Mar 31, 2023 -13.21 Mn
Dec 31, 2022 53.51 Mn
Sep 30, 2022 -16.82 Mn
Jun 30, 2022 -16.73 Mn
Mar 31, 2022 -17.60 Mn
Dec 31, 2021 -15.73 Mn
Sep 30, 2021 -12.67 Mn
Jun 30, 2021 -13.48 Mn